Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

113.49 +0.04 (+0.04%)
Official Closing Price Updated: 7:00 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,501,395
Open 114.27
Bid (Size) 110.22 (1)
Ask (Size) 115.70 (1)
Prev. Close 113.45
Today's Range 112.81 - 114.51
52wk Range 96.06 - 120.92
Shares Outstanding N/A
Dividend Yield 3.33%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline
Humana beat Q1 EPS estimates with $11.58, reaffirmed 2025 guidance, and outlined margin goals despite a drop in Medicare Advantage membership. 
Via Benzinga
Topics Earnings
Exposures Financial
Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
Novartis to buy Regulus for $0.8 billion upfront with potential for $1.7B total based on ADPKD drug milestone; deal set to close in H2 2025. 
Via Benzinga

Performance

YTD
+16.8%
+16.8%
1 Month
+1.8%
+1.8%
3 Month
+10.3%
+10.3%
6 Month
+3.3%
+3.3%
1 Year
+16.8%
+16.8%

More News

Read More
AppLovin Stock Tumbles After Edgewater Research Cuts Estimates Citing Rising Competition
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis
Via Stocktwits
Earnings Scheduled For April 29, 2025
Via Benzinga
Earnings Preview For Novartis
Via Benzinga
Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance
Via Benzinga
Topics Earnings
Exposures Financial
Novartis Creeps Toward A Breakout On Its Beat-And-Raise
Via Investor's Business Daily
Exposures Product Safety
US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week
Via Benzinga
General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
Via MarketBeat
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
The Smartest International Stock ETF to Buy With $100 Right Now
Via The Motley Fool
Topics ETFs Economy
Exposures Economy
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
Via The Motley Fool
Topics Economy Government Lawsuit
Exposures Financial Interest Rates Legal
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
Via Benzinga
S&P 500, Nasdaq Futures Rise After Stocks Dip Amid Trump's Jabs At Powell, Strong Yen Gives Nikkei A Volatile Start
Via Benzinga
Topics Economy Government Stocks
Exposures Interest Rates Political US Equities
3 Momentum Stocks That Could Soar Post-Market Volatility
Via MarketBeat
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Product Safety Tariff
Food for Thought: Results from a Food Allergy Survey of Caregivers
Via Brandpoint
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Mr. Ethan Billings recommends paying close attention to biotech stocks
Via Binary News Network
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Via Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Via Benzinga
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
Via Benzinga
Topics World Trade
Exposures Tariff

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 113.49
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 04/30/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.